in the present study the ability of local adoptive immunotherapy with human lymphokine-activated killer cells ( lakc ) and recombinant interleukin-2 ( il-2 ) to inhibit the growth of established squamous cell carcinoma of the head and neck was evaluated in nude mice .
C0086418
human
C0021756
recombinant interleukin-2